ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

Dronedarone

Also written as “Dabigatran etexilate plus dronedarone”, “Dronedarone (SR33589)” and “Dronedarone Hydrochloride Tablets”.

Its studies are mostly in Atrial Fibrillation · Heart Failure, led by 4 companies.

Drug pageDronedarone: every studyAll 29 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Dec 2, 200918 company-led studies, 0 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
Sanofiits history only140 open or runningphase 4since Dec 2, 2009Sep 13, 2005none ahead
Lunan Pharmaceutical Groupits history only20 open or runningno phasesince Jan 27, 2026Jan 27, 2026none ahead
Boehringer Ingelheim10 open or runningphase 1since Feb 28, 2011Feb 28, 2011none ahead
Gilead Sciencesits history only10 open or runningphase 2since Jan 18, 2012Jan 18, 2012none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Boehringer Ingelheim only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Feb 28, 2011First study: phase 1 study in HealthyFirst studyNCT01306162 · 36 enrolled · Germany

TargetBeta

“Voltage-gated L-type calcium channel blocker; Sodium channel alpha subunit blocker; Inward rectifier potassium channel 2 blocker; Potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 4 blocker”ChEMBL 37, by rule

Studies

The one study Boehringer Ingelheim leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT01306162Healthy · Germany1CompletedMay 201136

How it is read

Names in the registry

  • “Dronedarone”, 7 entries
  • “Dabigatran etexilate plus dronedarone”, 4 entries
  • “Dronedarone (SR33589)”, 4 entries
  • “Dronedarone Hydrochloride Tablets”, 2 entries
  • “dronedarone (SR33589)”, 2 entries

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.